71 related articles for article (PubMed ID: 15831512)
1. Association between single nucleotide polymorphisms of estrogen receptor alpha gene and efficacy of HRT on bone mineral density in post-menopausal Japanese women.
Yahata T; Quan J; Tamura N; Nagata H; Kurabayashi T; Tanaka K
Hum Reprod; 2005 Jul; 20(7):1860-6. PubMed ID: 15831512
[TBL] [Abstract][Full Text] [Related]
2. Correlation of estrogen receptor beta gene polymorphisms with spinal bone mineral density in peri- and post-menopausal Greek women.
Efstathiadou Z; Koukoulis G; Stakias N; Challa A; Zintzaras E; Tsatsoulis A
Maturitas; 2006 Mar; 53(4):380-5. PubMed ID: 16125346
[TBL] [Abstract][Full Text] [Related]
3. Test of linkage and/or association between the estrogen receptor alpha gene with bone mineral density in Caucasian nuclear families.
Zhao LJ; Liu PY; Long JR; Lu Y; Xu FH; Zhang YY; Shen H; Xiao P; Elze L; Recker RR; Deng HW
Bone; 2004 Aug; 35(2):395-402. PubMed ID: 15268889
[TBL] [Abstract][Full Text] [Related]
4. A differential association of ALOX15 polymorphisms with bone mineral density in pre- and post-menopausal women.
Cheung CL; Chan V; Kung AW
Hum Hered; 2008; 65(1):1-8. PubMed ID: 17652958
[TBL] [Abstract][Full Text] [Related]
5. The association between postmenopausal vertebral bone mineral density and estrogen receptor gene alleles in ethnic Japanese living in western Japan.
Ushiroyama T; Heishi M; Higashio S; Ikeda A; Ueki M
Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):15-24. PubMed ID: 11458981
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor alpha gene polymorphisms are associated with changes in bone remodeling markers and treatment response to estrogen.
Rapuri PB; Gallagher JC; Knezetic JA; Haynatzka V
Maturitas; 2006 Mar; 53(4):371-9. PubMed ID: 16139450
[TBL] [Abstract][Full Text] [Related]
7. Association of a single-nucleotide variation (A1330V) in the low-density lipoprotein receptor-related protein 5 gene (LRP5) with bone mineral density in adult Japanese women.
Ezura Y; Nakajima T; Urano T; Sudo Y; Kajita M; Yoshida H; Suzuki T; Hosoi T; Inoue S; Shiraki M; Emi M
Bone; 2007 Apr; 40(4):997-1005. PubMed ID: 17306638
[TBL] [Abstract][Full Text] [Related]
8. Association of vitamin D and estrogen receptor gene polymorphism with the effects of longterm hormone replacement therapy on bone mineral density.
Kurabayashi T; Matsushita H; Tomita M; Kato N; Kikuchi M; Nagata H; Honda A; Yahata T; Tanaka K
J Bone Miner Metab; 2004; 22(3):241-7. PubMed ID: 15108066
[TBL] [Abstract][Full Text] [Related]
9. ESR1 and APOE gene polymorphisms, serum lipids, and hormonal replacement therapy.
Almeida S; Fiegenbaum M; de Andrade FM; Osório-Wender MC; Hutz MH
Maturitas; 2006 May; 54(2):119-26. PubMed ID: 16242874
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor alpha and beta polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy?
Silvestri S; Thomsen AB; Gozzini A; Bagger Y; Christiansen C; Brandi ML
Menopause; 2006; 13(3):451-61. PubMed ID: 16735942
[TBL] [Abstract][Full Text] [Related]
11. Association between SNP and haplotypes in PPARGC1 and adiponectin genes and bone mineral density in Chinese nuclear families.
Zhang ZL; He JW; Qin YJ; Hu YQ; Li M; Liu YJ; Zhang H; Hu WW
Acta Pharmacol Sin; 2007 Feb; 28(2):287-95. PubMed ID: 17241533
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment.
Ohlendorff SD; Tofteng CL; Jensen JE; Petersen S; Civitelli R; Fenger M; Abrahamsen B; Hermann AP; Eiken P; Jørgensen NR
Pharmacogenet Genomics; 2007 Jul; 17(7):555-67. PubMed ID: 17558311
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of hormone replacement therapy for climacteric symptoms.
Takeo C; Ugai K; Araki J; Zhang L; Baba M; Ohashi W; Ueno K; Suzuki Y; Amano K; Hirai A; Muramatsu M
Biochem Biophys Res Commun; 2008 Oct; 374(4):604-8. PubMed ID: 18627768
[TBL] [Abstract][Full Text] [Related]
14. Association between serum cholesterol and bone mineral density.
Makovey J; Chen JS; Hayward C; Williams FM; Sambrook PN
Bone; 2009 Feb; 44(2):208-13. PubMed ID: 18983946
[TBL] [Abstract][Full Text] [Related]
15. The association of oestrogen receptor alpha-haplotypes with cardiovascular risk factors in the British Women's Heart and Health Study.
Lawlor DA; Timpson N; Ebrahim S; Day IN; Smith GD
Eur Heart J; 2006 Jul; 27(13):1597-604. PubMed ID: 16551651
[TBL] [Abstract][Full Text] [Related]
16. Effect of oestrogen replacement therapy on bone mass in post-menopausal Bangladeshi women.
Begum F; Shamsuddin L; Hussain MA; Chowdhury TA; Rahman M; Das TR
Bangladesh Med Res Counc Bull; 2001 Dec; 27(3):103-11. PubMed ID: 12197624
[TBL] [Abstract][Full Text] [Related]
17. Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis.
Mencej S; Albagha OM; Prezelj J; Kocjan T; Marc J
J Mol Endocrinol; 2008 Jun; 40(6):273-9. PubMed ID: 18502820
[TBL] [Abstract][Full Text] [Related]
18. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG
Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902
[TBL] [Abstract][Full Text] [Related]
19. Association between androgen receptor gene polymorphism and bone density in older women using hormone replacement therapy.
Retornaz F; Paris F; Lumbroso S; Audran F; Tigoulet F; Michelon C; Jeandel C; Sultan C; Blain H
Maturitas; 2006 Nov; 55(4):325-33. PubMed ID: 16759824
[TBL] [Abstract][Full Text] [Related]
20. Association of the estrogen receptor alpha gene polymorphisms with osteoporosis in the Mexican population.
Gómez R; Magaña JJ; Cisneros B; Pérez-Salazar E; Faugeron S; Véliz D; Castro C; Rubio J; Casas L; Valdés-Flores M
Clin Genet; 2007 Dec; 72(6):574-81. PubMed ID: 17953702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
